305 Results

People

  1. Seidman
    Seidman
  2. Aghajanian
    Aghajanian
  3. De Angelis
    De Angelis
  4. Hudis
    Hudis
  5. Kelsen
    Kelsen
  6. Lichtman
    Lichtman
  7. Saltz
    Saltz
  8. Scher
    Scher
  9. Bajorin
    Bajorin
  10. Fornier
    Fornier

Groups

  1. Department of Medicine (206)
  2. Solid Tumor Oncology Division (153)
  3. Survivorship Research (59)
  4. Hematologic Malignancies, Division of (51)
  5. Center for Hematologic Malignancies (47)
  6. Breast Medicine Service (43)
  7. Gastrointestinal Oncology Service (37)
  8. Surgery (29)
  9. Genitourinary Oncology Service (28)
  10. Center for Pancreatic Cancer Research (26)
  1. "peripheral neuropathy"
Formats
  1. Journal Article (283)
  2. Review (10)
  3. Conference Paper (6)
  4. Correspondence (3)
  5. Book Section (2)
  6. Guidelines (1)
Groups
  1. Department of Medicine (206)
  2. Solid Tumor Oncology Division (153)
  3. Survivorship Research (59)
  4. Hematologic Malignancies, Division of (51)
  5. Center for Hematologic Malignancies (47)
  6. Breast Medicine Service (43)

More Groups

People
  1. Andrew Seidman (16)
  2. Carol Aghajanian (12)
  3. Lisa De Angelis (12)
  4. Clifford Hudis (10)
  5. David Kelsen (10)
  6. Howard Scher (10)

More People

Years
  1. 2025 (9)
  2. 2024 (15)
  3. 2023 (19)
  4. 2022 (11)
  5. 2021 (7)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (26)
  2. Gynecologic Oncology (15)
  3. Lancet Oncology (14)
  4. Cancer (10)
  5. Annals of Oncology (9)
  6. Clinical Cancer Research (9)

More Publications

Publishers
  1. Elsevier Inc. (56)
  2. American Society of Clinical Oncology (26)
  3. Elsevier Science, Inc. (25)
  4. Springer (20)
  5. Wiley Blackwell (17)
  6. Oxford University Press (15)

More Publishers

Results (305)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ibrutinib associated with rituximab-platinum salt-based immunochemotherapy in B-cell lymphomas: Results of a phase 1b-II study of the LYSA group
    Journal Article

    Bonnet, C.; Dupuis, J.; Tilly, H.; Lamy, T.; Fruchart, C.; le Gouill, S.; Thieblemont, C.; Morschhauser, F.; Casasnovas, O.; Bouabdallah, K.; more...
    Cancers (2022)

    Fulltext@MSK | Save
  • Current approaches to management of newly diagnosed multiple myeloma
    Review

    Goel, U.; Usmani, S.; Kumar, S.
    American Journal of Hematology (2022)

    Fulltext@MSK | Save
  • Acupuncture for quality of life in gastric cancer patients undergoing adjuvant chemotherapy
    Journal Article

    Zhu, Y. J.; Wu, X. Y.; Wang, W.; Chang, X. S.; Zhan, D. D.; Diao, D. C.; Xiao, J.; Li, Y.; Ma, D.; Hu, M.; more...
    Journal of Pain and Symptom Management (2022)

    Fulltext@MSK | Save
  • Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory DLBCL: Survival update and new extension cohort data
    Journal Article

    Sehn, L. H.; Hertzberg, M.; Opat, S.; Herrera, A. F.; Assouline, S.; Flowers, C. R.; Kim, T. M.; McMillan, A.; Ozcan, M.; Safar, V.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Beyond chemotherapy and checkpoint inhibitors: Weighing the risks and benefits of the novel therapies for metastatic urothelial carcinoma
    Correspondence

    Powles, T.; Petrylak, D. P.; Rosenberg, J. E.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): A multicentre, open-label, phase 2a, multiple basket study
    Journal Article

    Javle, M.; Borad, M. J.; Azad, N. S.; Kurzrock, R.; Abou-Alfa, G. K.; George, B.; Hainsworth, J.; Meric-Bernstam, F.; Swanton, C.; Sweeney, C. J.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • Safety and effectiveness of weekly carfilzomib, lenalidomide, dexamethasone, and daratumumab combination therapy for patients with newly diagnosed multiple myeloma the MANHATTAN nonrandomized clinical trial
    Journal Article

    Landgren, O.; Hultcrantz, M.; Diamond, B.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Salcedo, M.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Postoperative extremity compartment syndrome in a cancer center: Incidence and risk factors
    Journal Article

    Vaynrub, M.; Or, O.; Drill, E.; Saulan, M.; Boland, P. J.
    Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): A multicentre, open-label, randomised, phase 3 trial
    Journal Article

    Bellmunt, J.; Hussain, M.; Gschwend, J. E.; Albers, P.; Oudard, S.; Castellano, D.; Daneshmand, S.; Nishiyama, H.; Majchrowicz, M.; Degaonkar, V.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis
    Journal Article

    Kim, Y. H.; Prince, H. M.; Whittaker, S.; Horwitz, S. M.; Duvic, M.; Bechter, O.; Sanches, J. A.; Stadler, R.; Scarisbrick, J.; Quaglino, P.; more...
    European Journal of Cancer (2021)

    Fulltext@MSK | Save